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ABSTRACT 
 
Background: Misoprostol is a PGE1 analogue is used to terminate pregnancies with great success. It is 
administered by various routes, oral, vaginal and rectal. Aims and Objectives: To evaluate the efficacy and side 
effects of oral and vaginal misoprostol in first and second trimester induced abortions. Materials and Methods: Our 
study included a total of 80 women, 40 each in first and second trimester. Patients in each trimester were divided 
into two groups of 20 and were given misoprostol by oral and vaginal route. Outcomes like complete abortion and 
side effects were observed. The statistical analysis was carried out using Statistical Package for Social Sciences 
(SPSS Inc.).  Results: Success rate of abortion In first trimester was 94 % and 86 % in oral and vaginal group 
respectively. In second trimester, the success rate was 94 % and 82 % in oral and vaginal group respectively. 
Conclusion: Oral and vaginal routes of misoprostol administration have similar efficacy and patient satisfaction 
level for first and second trimester induced abortions. Hence, oral route may serve as an alternative to vaginal 
misoprostol. 
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Introduction 
 
The termination of pregnancy before the period of 
viability is Termed as abortion. Statistical estimates 
have shown that worldwide approximately 40-60 
million abortions occur per year (about 26 million 
legally and 20 million illegally)[1-3]. In 1971, MTP 
was legalized in India[4]. 
Broadly there are 2 methods for abortions, medical and 
surgical, of which the former method is safer.  
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Different types of protocols are in use for pregnancy 
termination, like surgical techniques (D and E) and 
medical methods like intra-amniotic prostaglandin 
(PG) F2 α instillation, PGE2 vaginal suppositories, 
PGE2 and high-dose oxytocin. But all these methods 
require patients to be hospitalized hospitalization, 
exposure to surgical trauma and possibility of 
anaesthetic complications [5,6].Later In the years 2002 
and 2003, an amendment was made to the MTP Act 
sanctioning the obstetrician-gynecologists that they can 
give a combination of drugs mifepristone and 
misoprost in a clinical set up after 6 to 7 weeks of 
pregnancy. Now a days doctors are preferring oral 
mifepristone with misoprostol administered vaginally 
[7].Misoprostol is a PGE1 analogue, with a chemical 
formulae, C22H38O5 or (±) -methyl (13E)-11, 
16dihydroxy-16 methyl-9-oxo-prost-13-eonate. It was 
originally used to treat peptic ulcers, but was found to 
have uterotonic effect and hence was used for 
pregnancy termination with great success. It is 
available as 100 and 200 µg tablets. Various routes of 
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adminstration include oral, vaginal and rectal. The 
advantages of this drug is it is cost effective, and has 
few side effects [8,9].
 
Even though vaginal route of 
administration was proved to be effective, the fact that 
it requires repeated vaginal examinations, causing 
inconvenience to the patient makes it unacceptable. 
The advantages of oral route of administration are its 
ease of administration and lesser chances of infection.
10
  
We carried out our study to evaluate the efficacy and 
side effects of oral and vaginal misoprostol in first and 
second trimester induced abortions, so that to 
determine whether oral route can be an alternative to 
vaginal administration. 
 
Materials and Methods 
 
This is a prospective randomized trial carried out in the 
department of Obstetrics and Gynecology. The study 
was carried out from January 2015 to December 2015. 
Our study included 80 women were selected for first 
and second trimester induced abortions. Patients were 
divided into two groups and each patient was assorted 
to one of the groups by random number tables.  
The patients reported to the department for termination 
of pregnancy were screened for inclusion in the study. 
After explaining the patients about the study and 
obtaining approval from the Institutional ethics 
committee, a written informed consent was obtained 
from the patients. A detailed history about duration of 
amenorrhea, gravidity, parity, any previous 
spontaneous or induced abortions and medical diseases 
was recorded. Then general and systemic examination 
was carried out. Vaginal examination was done for all 
the women in order to evaluate the duration of 
pregnancy and also to rule out the presence of any 
pelvic pathology. The gestational age was determined 
by menstrual history and vaginal examination. 
Sonography was done if required. Routine 
investigations such as hemogram, BT, CT, blood sugar, 
urine examination, VDRL, sickling test, serum 
creatinine and HIV were carried out in all the included 
patients.  
 
Inclusion Criteria 
 
1. Patients of age 18 years and above  
2. Patients who came with request of an elective 
termination of pregnancy well within the MTP 
Act.  
3. Patients having an intrauterine pregnancy of less 
than or equal to 49 days for first trimester abortion 
and 14–20 weeks according to LMP for second 
trimester abortion, and also documented by 
ultrasonography.  
4. Patients who are ready to undergo required follow 
up and surgical management if required.  
 
Exclusion criteria 
 
1. Patients with respiratory tract disease, organic 
heart disease, diabetes mellitus, renal disease, 
Patients with pelvic pathology, uterine 
anomalies and hemorrhagic disorders,  
2. Patients with allergy to prostaglandins, 
3. Conditions which contraindicates the use of 
mifepristone like chronic corticosteroid 
administration and or adrenal disease,  
4. Conditions which contraindicates the use of 
misoprostol like glaucoma, mitral stenosis, 
sickle cell anemia, poorly controlled seizure 
disorders,  
5. If any attempt of intervention in the present 
pregnancy was done, 
6. Patients with Hemoglobin less than 10 g/dl 
and those with known clotting defects or who 
are receiving anticoagulation therapy 
 
First Trimester Abortions 
 
40 patients with pregnancy up to 49 days were selected 
and were divided into two groups of 20 each). 
1. Group 1: 200 mg mifepristone orally and 
misoprostol administration by oral route (Four 
tablets 200 mcg each) after 48 hours.  
2. Group 2: 200 mg mifepristone orally and and 
misoprostol administration by vaginal route (Four 
tablets 200 mcg each) after 48 hours.  
 Patients were followed up on 2
nd
, 14
th
 day and 
after 6 weeks and were also told to return if they had 
any complaints. On 14
th
 day, vaginal sonography was 
carried out to observe for any retained products of 
conception, if any termination was done by surgical 
method. Drug-related adverse effects and patient 
satisfaction were also recorded.   
 
Second trimester abortions 
40 women with 14–20 weeks pregnancy were divided 
into two groups:  
1. Group 1: 200 mg mifepristone orally and 
admitted after 48 hours. A first dose of 400 mcg of 
oral misoprostol followed by 200 mcg of oral 
misoprostol every 6 hourly until fetal expulsion or 
maximum 6 doses.  
2. 2.  Group 2: 200 mg mifepristone orally and admitted 
after 48 hours. 400 mcg intravaginal misoprostol every 
6 hourly until fetal expulsion or maximum 6 doses. 
Then oxytocin, 20 U in 500 mL of lactated Ringer 
solution at 125 mL/hour, was given to all patients until 
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delivery of the placenta. Patients were followed up on 
14
th
 and 42
th
 day or in between for any complaints.  
Parameters 
The outcomes measured were  
A. The efficacy as judged by complete abortion  
B. The induction interval (duration between initial 
misoprostol dose and till fetal expulsion),  
C. Drug-related adverse effects and  
D. Patient’s acceptability for route of administration.  
      The patients were kept under observation and the 
outcome was considered as successful if a complete 
abortion without surgical intervention was achieved. 
Then the patients were discharged and followed up 
regularly. They were given a questionnaire with 
inquiries regarding satisfaction level and effects. The 
obtained data was analyzed using the Statistical 
Package for Social Science (version 10.0 for Windows, 
SPSS).The observations were reported as mean and 
standard deviation. Success rate and side effects were 
analyzed by their percentage and compared by chi-
square test.  
 
Results 
 
In the first trimester, the effectiveness was assessed by 
complete abortion and was found to be 95 % in oral 
group and 90 % in vaginal group. One patient in oral 
group and two in vaginal group had retained products 
of conception after 2 weeks and were given 
misoprostol 400 mcg and had complete abortion at 1 
week follow up. In the second trimester, the 
effectiveness was found to be 95 % in oral group and 
85 % in vaginal group. One patient in oral group and 
three in vaginal group had retained products of 
conception, and after explaining them and obtaining 
consent, surgical intervention was carried out in order 
to obtain complete abortion. 
  
The demographic findings were comparable in both trimesters and both the groups (Table 1).  
Table 1: Demographic Parameters 
 First Trimester Second Trimester 
       Oral Vaginal Oral Vaginal 
Mean Age (Years) 27.14±4.32 29.01±4.04 24.52±5.01 23.21±4.02 
Socio-economic status Lower 0 1 2 5 
Middle 8 6 12 10 
Upper 12 13 6 5 
Background Urban 18 17 8 7 
Rural 2 3 12 13 
Mean period of gestation (weeks) 6.02±0.51 5.72±0.54 17.26±2.05 17.34±2.01 
 
The various reasons for which the abortion has to be carried out are listed in Table 2 
Table 2: Reasons of abortion 
Group Reasons Route of Administration P Value 
Oral Vaginal 
First Trimester Failure of contraception 20 (100 %) 20 (100 %) 0.171 
Second Trimester Congenital malformation 17 ( 85%) 14 ( 70%) 
Limiting number of Children 3 ( 15%) 2 ( 10%) 
Premature rupture of membranes with no liquor 0 3 ( 15 %) 
Failure of contraception 0 1 ( 5%) 
 
Various side effects were noticed after taking the drugs by both the routes (Table 3) 
Table 3: Drug-related adverse effects 
Group Route Altered Taste 
N(%) 
Nausea 
N(%) 
Vomiting N 
(%) 
Diarrhea N 
(%) 
Fever N (%) 
First 
Trimester 
Oral 3 (15 %) 5 (25 %) 0 0 0 
Vaginal 0 4 (20 %) 0 0 1 (5 %) 
P Value 0.037* 0.528 - - 0.312 
Second 
Trimester 
Oral 3 (15 %) 6 (30 %) 6 (30 %) 1 (5 %) 0 
Vaginal 0 1 (5 %) 2 (10 %) 0 1 (5 %) 
P Value 0.037* 0.010* 0.081 0.312 0.312 
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*=Statistically Significant 
The data obtained regarding patient satisfaction and comfort were obtained from the filled questionnaires (Table 4 
and 5, Graph 1) 
Table 4: Patient satisfaction levels 
Group Satisfaction level Route P Value 
Oral N (%) Vaginal N (%) 
First Trimester Satisfied 20 (100 %) 17 (85 %) 0.146 
Unsatisfied 0 3 (15 %) 
Second Trimester Satisfied 19 (95 %) 18 (90 %) 0.294 
Unsatisfied 1 (5 %) 2 (10 %) 
 
Table 5: Subjective assessments of patients comfort to the route of administration 
Characteristic Oral Vaginal 
Comfortable during administration 36 (90%) 24 (60%) 
Not Comfortable during administration 4 (10%) 16 (40%) 
 
Graph 1: Subjective assessments of patients comfort to the route of administration 
 
 
  
Discussion 
 
Medical methods of abortion is gaining popularity 
nowadays as it is simple, effective, comfortable to the 
patient and carries few complications than the surgical 
methods. Prostaglandin analogs like misoprostol are 
being commonly used [1,3]. 
In our study, we randomly assigned 80 women, 40 each 
of first and second trimester into 2 groups. Each group 
was given misoprostol by either oral or vaginal route.  
Retrospective studies about the safety of medical 
abortion showed a reduction in the serious infection 
rates and suggested that oral route has about similar 
efficacy and can substitute the vaginal route of 
administration [11]. We also found similar results and 
the difference between both routes was not statistically 
significant. Our results are in agreement with 
Middleton et al and Fjerstad et al[6,12].Few other 
studies have shown results in contrast to ours, vaginal 
route of misoprostol administration being more 
effective than other routes[13,14]. 
 Among the adverse effects of drugs, nausea was the 
most frequently reported one and was more in oral 
route and the difference was statistically significant. 
Altered taste sensation was more in oral route and the 
difference was also statistically significant. Our results 
are in agreement with Middleton et al[6]. The oral 
route of administration has high satisfaction rate and 
patients were very comfortable. Hence we suggest that 
oral route can be used as an alternative for women who 
feel uncomfortable with vaginal insertion of 
misoprostol. 
We could not find any statistically significant 
difference in induction time between the groups. Our 
findings are in accordance with Ellis et al [15]. 
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Conclusion 
 
Oral and vaginal routes of misoprostol was found to 
have similar effectiveness for first and second trimester 
induced abortions. Due to its high acceptability and 
more comfort to the patients, oral misoprostol can be 
used as an alternative route to vaginal route of 
administration. 
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